NEW YORK--(BUSINESS WIRE)--Apr 14, 2026--
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against REGENXBIO Inc. (“REGENXBIO” or the “Company”) (NASDAQ: RGNX) and reminds investors of the April 14, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414228046/en/
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose material adverse facts concerning the efficacy and safety of its RGX-111 trial study.
On January 28, 2026, REGENXBIO issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) placed a clinical hold on its investigational gene therapy, RGX-111, for the treatment of MPS I, also known as Hurler syndrome, following preliminary analysis of a single case of neoplasm (intraventricular CNS tumor) in a participant treated in its Phase I/II study." The press release also disclosed that "[t]he FDA also placed a clinical hold on RGX-121, for the treatment of MPS II, also known as Hunter Syndrome, citing the similarities in products, study populations, and shared risk between the clinical studies."
On this news, REGENXBIO's stock price fell $2.40 per share, or 17.9%, to close at $11.01 per share on January 28, 2026.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding REGENXBIO’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the REGENXBIO class action, go to www.faruqilaw.com/RGNX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of the Securities Class Action Lawsuit Deadline on April 14, 2026
NEW DELHI (AP) — India’s Parliament opened debate Thursday on a landmark bill to reserve one-third of legislative seats for women, which could set off a sweeping redrawing of voting boundaries that could sharpen political tensions nationwide.
If passed, the bill would fast-track a 2023 law mandating 33% reservation for women in Parliament and state legislatures. It would be one of the most consequential shifts in political representation since India’s independence and potentially widen female participation in a system where women remain underrepresented.
The quota, however, is linked to a controversial separate bill to change voting boundaries, a process that could increase the number of seats in the lower house from 543 to about 850.
While there appears to be a broad bipartisan support for putting more women into Parliament, opposition parties have raised concerns over changing voting boundaries, warning it could tilt the political balance in favor of Prime Minister Narendra Modi’s Bharatiya Janata Party.
The bills are being taken up during a three-day special session of Parliament and will require a two-thirds majority in both houses to pass. Modi’s ruling National Democratic Alliance holds 293 seats in Parliament, while a two-thirds majority would require 360 seats.
Several Asian countries, including India’s neighbors like Nepal and Bangladesh, have similar quotas for women in national legislatures. India already mandates that one-third of seats be set aside for women in local governance bodies, but women currently hold only about 14% of seats in the lower house of Parliament.
The quota could bring hundreds more women into legislative politics, which supporters say could redirect policy attention toward women’s health, education and gender-based violence. It is unclear how seats would be allocated to women in an expanded Parliament.
Ranjana Kumari, a women’s rights advocate, said the move would make India’s “democracy truly representative” and force political parties to field more female candidates.
“(The) door is little open. Women will enter and fill the room slowly,” Kumari said.
For many young Indian women, the change also carries symbolic weight.
Pranita Gupta, a 23-year-old law graduate, said it will instill “a sense of confidence that we can participate in politics and we can be part of Parliament not only as an exception but as well as a norm.”
The rollout of the quota is tied to a population-based redrawing of voting boundaries using data from the last completed census in 2011. While the timeline for this process remains unclear, the proposal has already triggered political debate.
Opposition parties warn that basing constituencies on population could shift political power toward faster-growing northern states, while diminishing the parliamentary representation, seat share and overall influence of southern regions. They also argue it could benefit Modi’s party, which has strong support in the northern states.
India’s Constitution mandates that parliamentary seats be allocated by population and revised after each census. However, boundaries have not been redrawn since the 1971 census, as successive governments delayed the process over concerns about uneven population growth.
Leaders in southern states, where birthrates have declined more sharply, say a population-based delimitation exercise could increase seats in the north and disadvantage southern regions that have slowed population growth and built stronger economies.
Modi’s party has pushed back on the criticism against the bill, with Parliamentary Affairs Minister Kiren Rijiju on Wednesday describing the concerns as misleading.
But early opposition surfaced Thursday, as Tamil Nadu chief minister M.K. Stalin burned a copy of the bill and raised a black flag in protest. He urged people across the state to do the same.
Some leaders from southern states also turned up in Parliament dressed in black as a mark of protest.
India’s opposition leader Rahul Gandhi alleged the exercise could be used to “gerrymander” parliamentary constituencies in favor of Modi’s party ahead of the 2029 national elections.
“Delimitation should be based on a transparent policy framework, developed after wide consultations with a consensus,” he wrote Wednesday on X.
Indian women lawmakers pose outside Parliament House before the start of the debate on a landmark bill to reserve one-third of seats for women, in New Delhi, India, Thursday, April 16, 2026. (AP Photo)
